Anhui BBCA Pharmaceuticals

Anhui BBCA Pharmaceuticals is a large-scale integrated pharmaceutical company based in China, specializing in the research, development, and manufacturing of a diverse range of medical products. The company is a leading producer of large-volume parenterals (IV fluids) and maintains a robust portfolio of finished dosage forms, including tablets, capsules, and injections across multiple therapeutic areas such as cardiovascular, anti-infective, and metabolic diseases. In addition to finished drugs, BBCA Pharmaceuticals is a significant manufacturer of active pharmaceutical ingredients (APIs) and medical devices. Listed on the Shenzhen Stock Exchange, the company operates several manufacturing bases and maintains a strong domestic and international distribution network.